Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A

Journal of Immunology

Volumn 165, Issue 12, 2000, Pages 7088-7095

  Smith, S M ^a   Brookes, R ^a   Klein, M R ^a   Malin, A S ^a   Lukey, P T ^a   King, A S ^a   Ogg, G S ^a   Hill, A V S ^a   Dockrell, H M ^a  

^a Immunology Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYCOBACTERIUM ANTIGEN;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS; VACCINATION; VACCINIA VIRUS;

EID: 0034671639     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.12.7088     Document Type: Article

References (59)

1. Global epidemiology of tuberculosis Morbidity and mortality of a world-wide epidemic
2. Tuberculosis commentary on a re-emergent killer
3. Cytokine production at the site of disease in human tuberculosis
4. Patterns of cytokine production by Mycobacterium tuberculosis-reactive human T-cell clones
5. + T-cell clones heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes
6. Cytokine secretion by CD4 T lympbocytes acquired in response to Mycobacterium tuberculosis infection
7. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice
8. Human T cell responses induced by vaccination with Mycobacterium bovis BCG
9. + cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway
10. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection
11. Immune response to Mycobacterium bovis bacille Calmette-Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice contribution of CD4 and CD8 T cells to acquired resistance
12. + cytotoxic T cells and relative resistance of alveolar macrophages to lysis
13. + T cells in vitro
14. + T cells reactive with Mycobacterium tuberculosis-infected antigen presenting cells
15. + T cells
16. Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and M avium
17. Immunity to intracellular bacteria
18. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perform- or granzyme-mediated cytolytic mechanisms
19. Perform, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice
20. + T cells requires the production of γ interferon
21. +, T cells in the lungs following aerosol infection with Mycobacterium tuberculosis
22. + T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice
23. + T lymphocytes specific for Mycobacterium tuberculosis
24. CTL response to Mycobacterium tuberculosis identification of an immunogenic epitope in the 19-kDa lipoprotein
25. + T cells in healthy contacts of tuberculosis
26. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection
27. Vaccination against tuberculosis by DNA injection
28. Therapy of tuberculosis in mice by DNA vaccination
29. The antigen 85 complex a major secretion product of Mycobacterium tuberculosis
30. Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis Bacillus Calmette-Guerin infected mice
31. b mice
32. T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy
33. Mapping of Th1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG
34. The Mycobacterium bovis 32-kilodalton protein antigen induces human cytolytic T-cell responses
35. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
36. Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A
37. + memory T cells
38. Quantification of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
39. Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent
40. Modern vaccines Mycobacterial disease
41. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo
42. Cutting edge rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma
43. Direct isolation, phenotyping, and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood
44. + T cells specific for EBV in healthy virus carriers
45. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytotoxic T lymphocytes
46. + T cells in individuals receiving highly active antiretroviral therapy (HAART)
47. + T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotrophic virus-associated myelopathy
48. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers
49. + T cells in peripheral blood and liver using peptide-MHC tetramers
50. Characterisation of circulating T cells specific for tumor-associated antigens in melanoma patients
51. + T cells produce antiviral cytokines but are impaired in cytolytic function
52. Levels of human Immunodefeciency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy
53. Longitudinal phenotypic analysis of human Immunodeficiency virus Type 1-specific cytotoxic T lymphocytes correlation with disease progression
54. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection
55. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway
56. Characterisation of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited
57. Sequestration of Mycobacterium tuberculosis in tight vacuoles in vivo in lung macrophages of mice infected by the respiratory route
58. Mycobacterial infection of macrophages results in membrane-permeable phagosomes
59. Characterisation of a haemolysin from Mycobacterium tuberculosis with homology to a virulence factor of Serpulina hyodysenteriae